Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|November 1, 2011
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysisGiuseppe Lombardi, Maria Ornella Nicoletto, Milena Gusella, et al.
Cell Death & Disease|May 30, 2019
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancerElena Laura Mazzoldi, Simona Pavan, Giorgia Pilotto, et al.
Anticancer Research|December 29, 2010
Bevacizumab and glioblastomas, a single-centre experience: how disease history and characteristics may affect clinical outcomeFable Zustovich, Giuseppe Lombardi, Davide Pastorelli, et al.
Oncology Reports|October 11, 2002
Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical studyMaria Ornella Nicoletto, Roberto Padrini, Manlio Palumbo, et al.
Open Access Journal of Urology|November 8, 2013
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinomaFable Zustovich, Giuseppe Lombardi, Davide Pastorelli, et al.
Critical Reviews in Oncology/Hematology|January 17, 2012
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysisMaurizia Dalla Palma, Michele Gregianin, Pasquale Fiduccia, et al.
Frontiers in Oncology|December 31, 2020
Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer CenterGiulia Tasca, Maria Vittoria Dieci, Zora Baretta, et al.
Anti-Cancer Drugs|December 3, 2009
Good response to second-line bevacizumab and interferon-alpha in a sunitinib-refractory patient with metastatic renal cell carcinomaDavide Pastorelli, Fable Zustovich, Giovanni Faggioni, et al.
Tumori|June 26, 2015
Trabectedin plus pegylated liposomal doxorubicin: retrospective analysis in heavily pretreated platinum-sensitive ovarian cancerMaria Ornella Nicoletto, Alessandra Baldoni, Alessandra Casarin, et al.
Journal of Clinical Medicine|February 5, 2020
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian CancerElena Laura Mazzoldi, Anna Pastò, Giorgia Pilotto, et al.
Pageof 4